In fact, one wag on Twitter compared the time taken to come up with logo to the mere seven months Pfizer and BioNtech needed to bring their COVID-19 vaccine through clinical testing: https ...
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses. The drugmaker ...
Pfizer generated $58 billion in total sales in 2023. Pharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles with diminishing demand for its COVID-19 ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...
Hosted on MSN10mon
Texas AG sues Pfizer for allegedly selling medicine it knew was ineffective, manipulated quality-test resultsTexas Attorney General Ken Paxton has sued Pfizer and its drug manufacturer for allegedly providing medicine it knew to be ineffective. In a lawsuit unsealed Monday, Paxton sued Pfizer ...
Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...
Meta Platforms logo on a sign in front of an office building ... In the company’s recent earnings report, Pfizer raised its 2024 adjusted EPS guidance to $2.45-$2.65, up from $2.25, and ...
In a report released today, Akash Tewari from Jefferies assigned a Buy rating to Pfizer (PFE – Research Report), with a price target of $35.00. The company’s shares closed yesterday at $30.07.
The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna ... and syringes with the ... [+] logo of US biotech company Novavax.
Pfizer Inc. (PFE) said Saturday that its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback
